Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Clarendon Fund Managers
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cloverleaf BioSeed $33M · this month • Founded 2023 • 51-200 employees • 3 roles
Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
AirnaSeries B $155M · 6 mo ago • Founded 2021 • 11-50 employees • 1 role
A bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common…
Borealisbio1-10 employees
Our team has extensive expertise in kidney disease, targeted delivery of RNA therapeutics, translational systems biology and data sciences…
SolaceSeries C $130M · 7 mo ago • Founded 2022 • 51-200 employees • 22 roles
Solace is on a health tech startup mission to empower patients, improve outcomes, and restore the promise of the U.S. healthcare system.
Atomic1 role
Oriented at the cutting edge of AI, RNA and structural biology Atomic AI operates at the intersection of revolutionary breakthroughs in…
AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous…

Overview

SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.